美股A股
StockGist

22nd Century Group, Inc.

XXIINASDAQ · Consumer Defensive · Tobacco
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness …
$0.77-40.76%
报价 2026-11-13
市值
$265,780
EV
$-4.7M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -100.0%
$0.77$19,836.00

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
XXII22nd Century Group, Inc.$265,780-40.8%+79.6%-10.2%–––
TANHTantech Holdings Ltd$26.7M+0.6%–18.6%–––
FAMIFarmmi, Inc.$3.8M-11.1%–-6.1%––0.1x
FEDUFour Seasons Education (Cayman) Inc.$1.7M+3.3%–25.8%0.7x––
GSUNGolden Sun Education Group Limited$1.5M-1.5%–1.8%–––
MYNDMynd.ai, Inc.$884,748-6.1%–21%–––
GNLNGreenlane Holdings, Inc.$615,713-8.2%–87.2%–––
同行中位数–––19.8%0.7x–0.1x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
2024-09-30
Q3 2024
Revenue$2.9M$4.1M$1M$1.5M$2.2M$2.3M$1.8M$2.5M
Gross Margin-10.2%-15.5%-79.6%-70.7%-28.5%-26.8%-68.1%-23.4%
Operating Margin-114.9%-74%-253.1%-214.4%-133.8%-113%-222.3%-134.3%
Net Income$-3.3M$-3.3M$-2.8M$5.5M$-3.4M$-4.3M$-4.6M$-3.8M
Diluted EPS-6,032-1,048.64-919.3401.94-11,838.96-50,082.42-356,813.1-1,486,714
Operating Cash Flow$-4M$-3.1M$2.7M$-4M$-3.5M$-3M$-4.4M$-3M

研究材料